"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,9,"Adverse events: hypoglycaemia (88 hours after drug bolus, or up to 4 years + 11 months)",NA,"SUBGROUP_AND_OVERALL","Sheth 2016",2016,0,1.47478812037526,0,0,9,44,0,0,0,39,0,2.175,14.372381,16.888889,1.015028,281.011482,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014802.pub2/full","10.1002/14651858.CD014802.pub2","9::overall","CD014802_pub2_data","significance_only",TRUE,TRUE,FALSE,1.6644118929259,0.112931288379138,0.403250758588127,2.92557302726368,-0.0445400377562572,0.270402614514533,FALSE,FALSE
1,9,"Adverse events: hypoglycaemia (88 hours after drug bolus, or up to 4 years + 11 months)",NA,"SUBGROUP_AND_OVERALL","Sheth 2022",2022,0,0,0,0,15,259,0,0,4,259,0,0,85.627619,3.75,1.261565,11.146867,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014802.pub2/full","10.1002/14651858.CD014802.pub2","9::overall","CD014802_pub2_data","significance_only",TRUE,TRUE,FALSE,1.6644118929259,0.112931288379138,0.403250758588127,2.92557302726368,-0.0445400377562572,0.270402614514533,FALSE,FALSE
